Clinicopathologic analysis of primary pure squamous cell carcinoma of the breast.
- Author:
Wei-guo HU
1
;
Bao-ning ZHANG
;
Li-xue XUAN
Author Information
- Publication Type:Journal Article
- MeSH: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; therapeutic use; Biopsy, Needle; Breast Neoplasms; diagnosis; pathology; therapy; Carcinoma, Squamous Cell; diagnosis; pathology; therapy; Chemotherapy, Adjuvant; Combined Modality Therapy; Female; Follow-Up Studies; Humans; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; methods; Middle Aged; Neoplasm Staging; Prognosis; Radiotherapy, Adjuvant; Retrospective Studies
- From: Chinese Journal of Oncology 2004;26(11):682-684
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo analyze the clinicopathologic characteristics and treatment method for primary pure squamous cell carcinoma of the breast.
METHODSTwelve patients with primary squamous cell carcinoma of the breast pathologically confirmed were retrospectively reviewed. The clinical characteristics, diagnosis, treatment and prognosis were analyzed.
RESULTSAll 12 patients were women with median age of 50 years (44-76 years). The patients all presented a single mass in the breast on presentation. The diameter ranged from 2.5 cm to 10.0 cm in diameter. All of the patients had undergone surgical resection. There were 6 cases in stage IIa, 2 in IIb, 2 in IIIa and 2 in IIIb according to the TNM staging system of AJCC and UICC. Ten of the 12 cases were followed-up from 4 months to 189 months.
CONCLUSIONPrimary squamous cell carcinoma of the breast is often in need of diagnosis by exclusion, but can be initially confirmed by fine needle aspiration. Presently, no standard therapy can be recommended in practice. The prognosis is controversial.